GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Merus NV (FRA:2GH) » Definitions » Accumulated other comprehensive income (loss)

Merus NV (FRA:2GH) Accumulated other comprehensive income (loss) : €-27.53 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Merus NV Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Merus NV's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €-27.53 Mil.

Merus NV's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 (€-35.08 Mil) to Dec. 2023 (€-20.66 Mil) but then declined from Dec. 2023 (€-20.66 Mil) to Mar. 2024 (€-27.53 Mil).

Merus NV's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€-8.16 Mil) to Dec. 2022 (€-28.74 Mil) but then increased from Dec. 2022 (€-28.74 Mil) to Dec. 2023 (€-20.66 Mil).

Merus NV Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Merus NV's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus NV Accumulated other comprehensive income (loss) Chart

Merus NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.43 7.46 -8.16 -28.74 -20.66

Merus NV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.48 -24.65 -35.08 -20.66 -27.53

Merus NV Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Merus NV Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Merus NV's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Merus NV (FRA:2GH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Merus NV (FRA:2GH) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
ABCL CVAC RYZB HRMY AGIO ZNTL RXRX MNKD TGTX SAGE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
MRUS:USA
Address
Uppsalalaan 17, Utrecht, NLD, 3584 CT
Website
https://www.merus.nl
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus only reportable segment comprising the discovery and development of innovative bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Merus NV (FRA:2GH) Headlines

No Headlines